Phase I Study of Oral CI-994 in Combination with Gemcitabine in Treatment of Patients with Advanced Cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Phase I Study of Oral CI-994 in Combination with Gemcitabine in Treatment of Patients with Advanced Cancer

Published:2003-01 Issue:1 Volume:9 Page:58-66
ISSN:1528-9117
Container-title:The Cancer Journal
language:en
Short-container-title:The Cancer Journal

Author:

Nemunaitis John J.,Orr Douglas,Eager Rob,Cunningham C. Casey,Williams Adrienne,Mennel Robert,Grove William,Olson Stephen

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Oncology

Reference54 articles.

1. New cytostatics—more activity and less toxicity

2. Preclinical antitumor activity of CI-994

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A neuronal cell-based reporter system for monitoring the activity of HDAC2;SLAS Discovery;2022-12

2. The Role of HDACs in the Response of Cancer Cells to Cellular Stress and the Potential for Therapeutic Intervention;International Journal of Molecular Sciences;2022-07-24

3. Epidemiological Assessment of Oral Cancer Burden in Pakistan;Cancer Investigation;2021-10-13

4. Zinc binding groups for histone deacetylase inhibitors;Journal of Enzyme Inhibition and Medicinal Chemistry;2018-01-01

5. Epigenetic therapy and chemosensitization in solid malignancy;Cancer Treatment Reviews;2017-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP